-
11
Mar, 2024
Drought Stress Memory At The Plant Cycle Level: A Review Part 1
Abstract: Plants are sessile organisms whose survival depends on their strategy to cope with dynamic, stressful conditions. It is urgent to improve the ability of crops to adapt to recurrent stress...
-
08
Mar, 2024
The Current Status Of Neuroprotection in Congenital Heart Disease Part 3
3.2. Semi-Quantitative Evaluation of Ectopic Mitochondrial DNA Images of Hsp60 staining (the mitochondrial matrix) and histone-H2B staining (the nuclear marker) were subtracted from images of dsDNA...
-
08
Mar, 2024
The Current Status Of Neuroprotection in Congenital Heart Disease Part 2
The microscopic images were then subjected to image calculation using ImageJ software (National Institutes of Health, Bethesda, MD, USA). The signal of Hsp60 was multiplied by "x". Hsp60 is an impo...
-
07
Mar, 2024
The Current Status Of Neuroprotection in Congenital Heart Disease Part 1
Abstract: The presence of ectopic DNA in the cytoplasm induces inflammation and cell death. It has been widely reported that leakage of nuclear DNA into the cytoplasm can mainly be sensed by cyclic...
-
07
Mar, 2024
Furman-2021-Augmenting Frontal Dopamine Tone E.pdf Part 3
Drug x decile effects did not reach statistical significance for any of the other task conditions (CF-S: 0.08±2.9, z = 0.03; CL-S: 2.49±2.3, z=1.08; CL-G: -.33±3.5, z=-0.09), though notably, the tr...
-
07
Mar, 2024
Furman-2021-Augmenting Frontal Dopamine Tone E.pdf Part 2
Importantly, context-first (CF) and context-last (CL) trials, irrespective of whether they are selective or global, are not distinguished by other factors, such as conflict during response selectio...
-
07
Mar, 2024
Furman-2021-Augmenting Frontal Dopamine Tone E.pdf Part 1
Acknowledgments: This work was supported by funding from the National Institute of Mental Health (R01 112775 to MH & AK) and the Office of Naval Research (MURI N00014-16-1-2832 to DB). The auth...
-
06
Mar, 2024
The Current Status Of Neuroprotection in Congenital Heart Disease Part 3
Although developments in the understanding of minocycline's neuroprotective capacity suggest potential applications for attenuation of neurologic injury, it should be remembered that in neonates, t...
-
06
Mar, 2024
The Current Status Of Neuroprotection in Congenital Heart Disease Part 2
3. Maternal Neuroprotection-Preclinical Studies for Future Translation Tetrahydrobiopterin Tetrahydrobiopterin (BH4) is a key component of neuronal NO synthase function. During cerebral hypoxia, BH...
-
06
Mar, 2024
The Current Status Of Neuroprotection in Congenital Heart Disease Part 1
Abstract: Neurological deficits are a serious and common sequelae of congenital heart disease (CHD). While their underlying mechanisms have not been fully characterized, their manifestations are we...
-
05
Mar, 2024
Structural Brain Changes Associated With Overweight And Obesity Part 3
5. Microscopic Brain Changes One of the initial reports on the adverse effects of experimental obesity in brain pathology described the alterations in the lipid composition of myelin in genetically...
-
05
Mar, 2024
Structural Brain Changes Associated With Overweight And Obesity Part 2
Table 1 lists the cytokines and chemokines induced by various cell types and activation states of the cells (either quiescent or activated) in fatty tissue outside the CNS and their relations to mi...
